0001420506-19-000819.txt : 20190813 0001420506-19-000819.hdr.sgml : 20190813 20190813164411 ACCESSION NUMBER: 0001420506-19-000819 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190813 DATE AS OF CHANGE: 20190813 EFFECTIVENESS DATE: 20190813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RHO CAPITAL PARTNERS INC CENTRAL INDEX KEY: 0001020455 IRS NUMBER: 133087622 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-05883 FILM NUMBER: 191021289 BUSINESS ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2127516677 MAIL ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: RHO MANAGEMENT CO INC DATE OF NAME CHANGE: 19960806 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001020455 XXXXXXXX 06-30-2019 06-30-2019 false RHO CAPITAL PARTNERS INC

152 WEST 57TH STREET 23RD FLOOR NEW YORK NY 10019

13F HOLDINGS REPORT 028-05883 N Peter E. Kalkanis 2127516677 Peter E. Kalkanis, Chief Financial Officer NEW YORK NY 08-12-2019 0 5 144163 false INFORMATION TABLE 2 Form13F_InfoTable.xml INFORMATION TABLE FOR RHO CAPITAL PARTNERS INC CARA THERAPEUTICS INC COM 140755109 70263 3268057 SH SOLE 3268057 0 0 LIVEXLIVE MEDIA INC COM NEW 53839L208 15204 3663540 SH SOLE 3663540 0 0 MERSANA THERAPEUTICS INC COM 59045L106 3226 796458 SH SOLE 796458 0 0 NGM BIOPHARMACEUTICALS INC COM 62921N105 55144 3766667 SH SOLE 3766667 0 0 SENSEONICS HLDGS INC COM 81727U105 326 159601 SH SOLE 159601 0 0